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Editor’s key points
† During emergence from
general anaesthesia,
coughing (or bucking),
hypertension and
tachycardia may result in
complications such as
postoperative
haemorrhage,
intracranial and
intraocular hypertension
or haematoma.
† Remifentanil
administration by
effect-site
target-controlled infusion
suppressed cough,
hypertension and
tachycardia during
anaesthetic emergence
more effectively than i.v.
bolus administration of
lidocaine.
Background. I.V. lidocaine administration and target-controlled infusion (TCI) of
remifentanil may each be used to reduce cough and haemodynamic stimulation during
emergence from general anaesthesia. We therefore compared the effects of these two
treatments on patients’ responses to the tracheal tube during recovery from general
anaesthesia after thyroid surgery.
Methods. Seventy female patients undergoing thyroidectomy under general anaesthesia
using sevoflurane and remifentanil were randomly assigned to i.v. lidocaine (Group L,
n¼35) or remifentanil by TCI (Group R, n¼35). At the end of surgery, sevoflurane was
turned off, and the remifentanil infusion was stopped in Group L and maintained in
Group R at an effect-site concentration of 2.0 ng ml21 until extubation. At the same
time, i.v. lidocaine 1.5 mg ml21 was administered in Group L. The incidence and severity
of cough, haemodynamic parameters, and recovery profiles were evaluated during the
emergence.
Results. The incidence of cough during the emergence was significantly higher in Group L
than in Group R (72.7% vs 20.6%, P,0.001) and so was the grade of cough (P,0.001). The
mean arterial pressure and heart rate were significantly lower in the R group than in the L
group during the emergence period (P,0.05), although the two groups showed comparable
recovery profiles.
Conclusions. TCI of remifentanil reduces responsiveness to the tracheal tube during
emergence from general anaesthesia more effectively than does i.v. lidocaine in female
patients undergoing thyroid surgery.
Keywords: anaesthesia, general; anaesthetics local, lidocaine; analgesics opioids,
remifentanil; complications, extubation tracheal; drug delivery; infusion
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During emergence from general anaesthesia, responses that
result from the airway reflex such as coughing (or bucking)
are common, and the incidence of cough is reported to be
76–80%.1 2 Occasionally, cough is accompanied by hyper-
tension and tachycardia,3 4 and they may result in post-
operative haemorrhage,5 intracranial hypertension,3 or
intraocular hypertension.6 After thyroid surgery, it is impor-
tant to prevent such responses because they may induce
postoperative haemorrhage and a potentially fatal cervical
haematoma.7
Techniques used to reduce coughing during emergence
include lidocaine4 8 and opioids.9 10 I.V. lidocaine has been
thoroughly investigated and is reported to suppress emer-
gence cough without risk for serious complication.4 8 11 On
the other side, remifentanil via target-controlled infusion
(TCI) has recently proved to reduce cough and
haemodynamic stimulation during recovery from general
anaesthesia without delaying emergence.12 13
We designed the present study to compare the antitussive
effects of the conventionally used lidocaine and the newly
investigated TCI of remifentanil during recovery from
general anaesthesia. In addition, we aimed to evaluate and
compare the effects of these two treatments on haemo-
dynamic response and recovery profiles.
Methods
The study was approved by the institutional review board
of Severance Hospital, Yonsei University Health System
(ref: 4-2009-0519) and registered at ClinicalTrials.gov (ref:
NCT01082458). We obtained written informed consent from
all subjects.
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For this study, we enrolled 70 consecutive patients, all
females aged 20–65 yr and ASA physical status I–II, who
underwent general anaesthesia for elective thyroidectomy
due to thyroid neoplasm. Exclusion criteria included signs
of a difficult airway, increased risk of perioperative aspiration,
history of chronic respiratory disease such as chronic obstruc-
tive pulmonary disease or asthma, recent respiratory tract
infection, chronic coughing, current smoking, and significant
cardiovascular, hepatic, or renal disease. This randomized,
double-blinded, controlled trial took place at the operating
theatre of Severance Hospital in Seoul, Korea, from February
2010 to May 2010.
Patients were randomly assigned to one of the two treat-
ment groups according to a computer-generated random
numbers table. Patients received either i.v. lidocaine 1.5 mg
kg21 (Group L) or a predicted effect-site concentration (Ce)
of 2.0 ng ml21 of remifentanil by TCI (Group R) for emergence
from anaesthesia. For effect-site TCI of remifentanil, a
commercial TCI pump (Orchestraw Base Primea, Fresenius
Vial, France) was used, and pump operation was based on
Minto and colleagues’ pharmacokinetic model for remifenta-
nil. Our protocol was based on targeted effect-site
concentration.
All patients were premedicated with i.v. midazolam 0.05
mg kg21 30 min before induction and i.v. glycopyrrolate 0.2
mg just before induction of anaesthesia. Electrocardiogram,
peripheral oxygen saturation (SpO2 ), non-invasive arterial
pressure, end-tidal carbon dioxide (E′CO2 ), and nasopharyn-
geal temperature were monitored at 5 min intervals. Anaes-
thesia was induced using i.v. propofol 1.5 mg kg21 and
effect-site TCI of remifentanil. After the patient was unable
to respond to verbal response, i.v. rocuronium 0.6 mg kg21
was administered. Tracheal intubation was performed in all
patients using a 7.0 mm (internal diameter) reinforced tra-
cheal tube and cuff pressure was maintained at 20–25 mm
Hg with a hand pressure gauge (Hi-LoTM Hand Pressure
Gauge, VBM Medizintechnik GmbH, Germany) throughout
the procedure. Anaesthesia was maintained with sevoflurane
and effect-site TCI of remifentanil, which were titrated to
maintain arterial pressure and heart rate (HR) within 10–
20% of pre-induction values. Sevoflurane and remifentanil
were kept within the range of 1.2–2.5% and 2–5 ng ml21,
respectively. Mechanical ventilation was maintained with a
tidal volume of 8 ml kg21, and ventilatory frequency was
adjusted to maintain E′CO2 at 4.6–5.3 kPa. Temperature was
maintained at 36–378C.
Two practitioners were involved during the emergence
phase. The first anaesthetist knew which group the patient
was in, but the second anaesthetist did not. When a surgeon
started to suture the subcutaneous tissue, the first anaesthe-
tist shielded the TCI pump from the second anaesthetist and
stopped the TCI of remifentanil in patients assigned to Group
L, but maintained Ce 2.0 ng ml21 by TCI of remifentanil in
patients assigned to Group R. At the same time, the second
anaesthetist adjusted sevoflurane to 0.8 minimal alveolar
concentration (MAC) (1.4–1.6%, adjusted to age) in all
patients. The second anaesthetist performed all tasks
related to emergence from general anaesthesia, as well as
the monitoring and recording needed for this study except
for control of the TCI pump and i.v. lidocaine or i.v. saline
administration. After completion of skin suture, ketorolac 0.5
mg kg21 was given for pain control and glycopyrrolate 0.004
mg kg21 with neostigmine 0.02 mg kg21 was given to
reverse the neuromuscular block. Reversal was confirmed as
a train-of-four response greater than 90%. After the end of
surgery and return from the fully extended position to the
neutral position, the first anaesthetist administered 0.15 ml
kg21 of i.v. saline to the patients of Group R and 1.5 mg kg21
of i.v. lidocaine to the patients of Group L. At the same time,
the second anaesthetist turned sevoflurane off. Mechanical
ventilation was then converted to manual ventilation and
E′CO2 was maintained at 4.6–5.9 kPa in both groups. Manual
ventilation continued until the patients breathed spon-
taneously, and mild hypercapnia was permitted to restore
spontaneous respiration during manual ventilation. The
patients were not disturbed, except by continual verbal
requests to open their eyes, and all other stimuli were
avoided. When the patients opened their eyes, they were
encouraged to breathe deeply. After spontaneous respiration,
adequate tidal volume, and ventilatory frequency were con-
firmed, the trachea was extubated and oxygen was immedi-
ately supplemented via a facemask for 5 min. After
confirmation of stable respiratory and circulatory conditions,
patients were transported to the post-anaesthetic care unit
(PACU).
The time periods from the end of surgery (sevoflurane dis-
continuation) to eye opening and to extubation were
recorded. During emergence, which was defined as the
time interval from the end of surgery to 5 min after extuba-
tion, the level of cough was assessed and recorded by the fol-
lowing cough grading system: Grade 0, no cough; Grade 1,
single cough with mild severity; Grade 2, cough persistence
less than 5 s with moderate severity; Grade 3, severe, persist-
ent cough for more than 5 s (bucking). Cough was defined as
a sudden contraction of the abdomen. The mean arterial
pressure (MAP) and HR were also recorded at the following
time points: T0, before induction of anaesthesia (baseline);
T1, the end of surgery; T2, immediately before extubation;
T3, 5 min after extubation. In addition, the level of sedation
and the ventilatory frequency were estimated and recorded
at the T3 point. Sedation was graded by the following seda-
tion grading system (SGS): Grade 0, deeply sedated and unre-
sponsive; Grade 1, sedated but responsive to light glabellar
tap or loud voice; Grade 2, sedated but responsive to
normal voice; Grade 3, awake and responding.
A third anaesthetist investigated the occurrence of hyper-
tension, postoperative pain, sedation, and nausea in the
patients during their PACU stay. The parameters of interest
were defined by the following criteria: hypertension, an
increase of 30% from MAP to T0 shown by estimation at suc-
cessive 5 min intervals; pain, more than five points on the
visual analogue scale; residual sedation, less than Grade 2
on the SGS at 10 min after PACU admission; nausea, need
for antiemetic treatment.
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The incidence of cough after general anaesthesia is
76%.1 A power analysis indicated that a sample size of
35 patients in each group would be required to detect a
difference in cough-suppressive capacity with a¼0.05 and
a power of 80% with the assumption that a 2.0 ng ml21
effect-site concentration of remifentanil by TCI could
decrease the incidence of cough by 90%12 and i.v. lidocaine
1.5 mg kg21 could reduce it by 50%.
All data are expressed as mean (SD), median (range), or
number (proportion, %). Data were analysed using SPSS
version 15.0 (SPSS Inc., Chicago, IL, USA). Normally distribu-
ted continuous variables were compared using an unpaired
two-tailed Student’s t-test or by repeated measures analysis
of variance with the Bonferroni correction. Continuous data
not normally distributed were analysed using the Mann–
Whitney U-test. Categorical data were analysed using the
x2 test or Fisher’s exact test where appropriate. A P-value
of ,0.05 was considered statistically significant.
Results
Of 82 patients assessed, 70 patients were enrolled in the
study. Among the enrolled patients, three patients were
dropped from this study on the day of operation. Sixty-seven
patients were able to complete all the assessments for this
study [Group L (n¼33); Group R (n¼34)] (Fig. 1). Physical
characteristics and the duration of anaesthesia in these
patients were comparable between the two groups (Table 1).
The incidence of cough during emergence from general
anaesthesia was significantly higher in Group L than in
Group R (72.7% vs 20.6%, P,0.001). Also the grade of
cough during the emergence was significantly higher in
Group L than in Group R (P,0.001) (Table 2).
Estimates of other parameters related to emergence from
general anaesthesia are shown in Table 3 and Figs 2 and 3.
The time periods from sevoflurane discontinuation to eye
opening (7.3 min in Group L vs 7.2 min in Group R) and to
extubation (8.3 min in Group L vs 8.3 min in Group R) were
comparable between the two groups. In addition, the
groups did not differ in sedation grade and ventilatory fre-
quency at 5 min after extubation, whereas the MAP and HR
were significantly lower in the R group than in the L group
during the emergence period (P,0.05).
The duration of PACU stay and the between-groups com-
parison of adverse outcomes at the PACU are summarized
in Table 4. The groups did not differ significantly in the dur-
ation of PACU stay or incidence of hypertension, pain, and
nausea at PACU. However, the number of patients with
residual sedation during the first 10 min at PACU was
Assessed for eligiblity (n = 82)
Excluded (n = 12)
• Not meeting inclusion criteria (n = 7)
• Declined to participate (n = 5)
• Other reasons (n = 0)
Allocated to Group R (n = 35)
• Received allocated intervention (n = 34)
• Did not receive allocated intervention (upper
 respiratory infection) (n = 1)
Allocated to Group R (n = 35)
• Received allocated intervention (n = 33)
• Did not receive allocated intervention (upper
 respiratory infection and paroxysmal
 hypertension) (n = 2)
Lost to follow-up (n = 0)
Discontinued intervention (n = 0)
Lost to follow-up (n = 0)
Discontinued intervention (n = 0)
Analysed (n = 33)
• Excluded from analysis (n = 0)
Analysed (n = 34)
• Excluded from analysis (n = 0)
Allocation
Follow-up
Analysis
Enrollment
Randomized (n = 70)
Fig 1 CONSORT diagram showing the flow of participants through each stage of our randomized trial. L, i.v. lidocaine; R, TCI of remifentanil.
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significantly greater in Group L than in Group R (27.3% vs 0%,
P¼0.001).
Discussion
In the present study, remifentanil administration by effect-
site TCI suppressed cough, hypertension, and tachycardia
during anaesthetic emergence more effectively than i.v.
bolus administration of lidocaine in female patients under-
going thyroid surgery. The two treatments did not differ in
their recovery profiles, which included the time interval
from sevoflurane discontinuation to extubation, level of
sedation, and ventilatory frequency after extubation.
The effects of lidocaine to prevent cough during recovery
from general anaesthesia have been thoroughly investigated
and have been conventionally used. The newly investigated
remifentanil TCI may be used during emergence for cough
suppression because of its short half-life and expected
offset. Several studies showed that i.v. lidocaine at 1–2 mg
kg21 is effective without risk for serious complications.4 8 11
In the previous study, 2.14 and 1.46 ng ml21 of remifentanil
Ce were represented as EC95 and EC50 to abolish cough, and
patients who received Ce 2.0 ng ml21 of remifentanil did not
suffer significant respiratory complications during anaes-
thetic induction14 or emergence.12 We compared the
method of i.v. bolus lidocaine 1.5 mg kg21 and Ce 2.0 ng
ml21 of remifentanil by TCI.
The lesser efficacy of i.v. bolus lidocaine compared with
remifentanil TCI is possibly due to the administration of lido-
caine as an i.v. bolus. Sodium channel blockers such as lido-
caine or mexiletine suppress cough by inhibiting action
potential formation in tracheal touch-sensitive Ad fibres
(cough receptors) at specific concentrations.15 A serum lido-
caine concentration of more than 3 mg kg21 may completely
suppress the cough reflex,16 although this relatively high
concentration is difficult to achieve in a timely manner by
bolus administration. On the other hand, remifentanil
administration via TCI can maintain a predictable plasma
concentration or effect-site concentration with an acceptable
level of bias and inaccuracy;17 18 and at this effect-site
concentration, remifentanil effectively attenuates coughing
Table 2 Cough profiles by group. Values are number (proportion)
or median (range). L, i.v. lidocaine; R, TCI of remifentanil; Grade of
cough: Grade 0, no cough; Grade 1, single cough with mild
severity; Grade 2, cough persistence less than 5 s with moderate
severity; Grade 3, severe, persistent cough for more than 5
s. *P,0.001 vs lidocaine group
Group L (n533) Group R (n534)
Cough occurrence 24 (72.7%) 7 (20.6%)*
Grade of cough 1 (1–3) 0 (0–2)*
Total number of patients according to cough grade
Grade 0 9 (27.3%) 27 (79.4%)
Grade 1 9 (27.3%) 3 (8.8%)
Grade 2 7 (21.2%) 4 (11.8%)
Grade 3 8 (24.2%) 0 (0%)
Table 1 Patient characteristics and the duration of anaesthesia
by group. Values are mean (range), mean (SD) or numbers. L, i.v.
lidocaine; R, TCI of remifentanil
Group L (n533) Group R (n534)
Age (yr) 45.8 (29–65) 43.0 (26–60)
ASA physical status (I/II) 28/5 29/5
Height (cm) 158.8 (5.9) 159.4 (5.5)
Weight (kg) 59.5 (8.8) 57.6 (8.1)
Duration of anaesthesia
(min)
109.8 (21.7) 117.7 (27.5)
Table 3 Recovery profiles by group. Values are mean (SD) or
median (range). L, i.v. lidocaine; R, TCI of remifentanil; Time to eye
opening, time period from the end of surgery to eye opening; Time
to extubation, time period from the end of surgery to extubation;
Grade of sedation: Grade 0, deeply sedated and unresponsive;
Grade 1, sedated but responsive to light glabellar tap or loud
voice; Grade 2, sedated but responsive to normal voice; Grade 3,
awake and responding; T3, 5 min after extubation. Both groups
show comparable recovery profiles
Group L
(n533)
Group R
(n534)
Time to eye opening (min) 7.3 (1.8) 7.2 (2.2)
Time to extubation (min) 8.3 (1.9) 8.3 (2.4)
Grade of sedation at T3 2 (2–3) 2 (2–3)
Ventilatory frequency at T3
(beats min21)
10.6 (3.0) 10.3 (3.2)
130
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80
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*
Fig 2 Change in MAP during emergence from general anaesthe-
sia. L, i.v. lidocaine; R, TCI of remifentanil; MAP, mean arterial
pressure; T0, before induction of anaesthesia; T1, the end of
surgery; T2, immediately before extubation; T3, 5 min after extu-
bation. The mean change in arterial pressure during emergence
of Group R is significantly different from that of Group L
(P,0.001). *P,0.05 vs Group R.
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because the probable site of antitussive action for the opioid
lies within the central nervous system.15
In addition to this advantage, the effect-site TCI of remifen-
tanil showed acceptable recovery profiles for sedation and
ventilatory frequency after extubation and for adverse out-
comes at the PACU. In contrast, although i.v. lidocaine
induced a grade of sedation immediately after surgery com-
parable with that of remifentanil TCI, it also increased the inci-
dence of residual sedation at the PACU. This is consistent with
animal studies showing that i.v. lidocaine at a serum concen-
tration of only 1 mg ml21 may reduce the MAC of halothane by
40%.19 Some studies also describe sedation or delayed emer-
gence related to i.v. lidocaine in clinical settings.11 20
In the context of thyroid surgery, cervical haematoma is a
well-known and dreaded complication. Possible causes of
this event include coughing during recovery from anaesthe-
sia and increased arterial pressure in the immediate
postoperative period.21 In particular, coughing during and
after removal of the tracheal tube may cause a ligature to
slip or non-ligated small vessels to bleed profusely because
of increased venous pressure.7 To reduce the risk of a fatal
complication in thyroid surgery, it is therefore important to
achieve a smooth emergence.
Our study is first limited by the inclusion of only young or
middle-aged females in the patient population. This is due to
the greater prevalence of thyroid cancer in females22 and is
further complicated due to a gender-related difference in
recovery time after sevoflurane anaesthesia.23 These
factors should be considered when interpreting our data.
Secondly, there is no control group to which we might
compare the effects of i.v. lidocaine on response to the tra-
cheal tube. Hence, it was difficult to find out whether i.v. lido-
caine actually attenuated coughing or not; the incidence of
cough in the lidocaine group was about 73%, which is
similar to the overall incidence of cough in a previous
study.1 During thyroid surgery, however, the trachea is phys-
ically manipulated, which may result in a higher incidence of
cough than in general surgery overall.
In conclusion, TCI of remifentanil reduces responsiveness
to the tracheal tube during the emergence from general
anaesthesia more effectively than does i.v. bolus adminis-
tration of lidocaine in female patients undergoing thyroid
surgery. In addition, TCI of remifentanil and i.v. bolus lido-
caine show comparable recovery profiles.
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